Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, 17165 Solna, Sweden.
Division of Nanobiotechnology, Department of Protein Science, Science for Life Laboratory, KTH Royal Institute of Technology, 17165 Solna, Sweden.
Acc Chem Res. 2021 Nov 2;54(21):3979-3990. doi: 10.1021/acs.accounts.1c00438. Epub 2021 Oct 12.
The development of robust methods allowing the precise detection of specific nucleic acid sequences is of major societal relevance, paving the way for significant advances in biotechnology and biomedical engineering. These range from a better understanding of human disease at a molecular level, allowing the discovery and development of novel biopharmaceuticals and vaccines, to the improvement of biotechnological processes providing improved food quality and safety, efficient green fuels, and smart textiles. Among these applications, the significance of pathogen diagnostics as the main focus of this Account has become particularly clear during the recent SARS-CoV-2 pandemic. In this context, while RT-PCR is the gold standard method for unambiguous detection of genetic material from pathogens, other isothermal amplification alternatives circumventing rapid heating-cooling cycles up to ∼95 °C are appealing to facilitate the translation of the assay into point-of-care (PoC) analytical platforms. Furthermore, the possibility of routinely multiplexing the detection of tens to hundreds of target sequences with single base pair specificity, currently not met by state-of-the-art methods available in clinical laboratories, would be instrumental along the path to tackle emergent viral variants and antimicrobial resistance genes. Here, we advocate that padlock probes (PLPs), first reported by Nilsson et al. in 1994, coupled with rolling circle amplification (RCA), termed here as PLP-RCA, is an underexploited technology in current arena of isothermal nucleic acid amplification tests (NAATs) providing an unprecedented degree of multiplexing, specificity, versatility, and amenability to integration in miniaturized PoC platforms. Furthermore, the intrinsically digital amplification of PLP-RCA retains spatial information and opens new avenues in the exploration of pathogenesis with spatial multiomics analysis of infected cells and tissue.The Account starts by introducing PLP-RCA in a nutshell focusing individually on the three main assay steps, namely, (1) PLP design and ligation mechanism, (2) RCA after probe ligation, and (3) detection of the RCA products. Each subject is touched upon succinctly but with sufficient detail for the reader to appreciate some assay intricacies and degree of versatility depending on the analytical challenge at hand. After familiarizing the reader with the method, we discuss specific examples of research in our group and others using PLP-RCA for viral, bacterial, and fungal diagnostics in a variety of clinical contexts, including the genotyping of antibiotic resistance genes and viral subtyping. Then, we dissect key developments in the miniaturization and integration of PLP-RCA to minimize user input, maximize analysis throughput, and expedite the time to results, ultimately aiming at PoC applications. These developments include molecular enrichment for maximum sensitivity, spatial arrays to maximize analytical throughput, automation of liquid handling to streamline the analytical workflow in miniaturized devices, and seamless integration of signal transduction to translate RCA product titers (and ideally spatial information) into a readable output. Finally, we position PLP-RCA in the current landscape of NAATs and furnish a systematic Strengths, Weaknesses, Opportunities and Threats analysis to shine light upon unpolished edges to uncover the gem with potential for ubiquitous, precise, and unbiased pathogen diagnostics.
开发能够精确检测特定核酸序列的稳健方法具有重要的社会意义,为生物技术和生物医学工程的重大进展铺平了道路。这些进展包括从分子水平更好地了解人类疾病,从而发现和开发新型生物制药和疫苗,到改进生物技术过程,提供提高食品质量和安全性、高效绿色燃料和智能纺织品。在这些应用中,病原体诊断的重要性作为本报告的主要焦点,在最近的 SARS-CoV-2 大流行期间变得尤为明显。在这方面,虽然 RT-PCR 是明确检测病原体遗传物质的金标准方法,但其他避免快速加热-冷却循环至约 95°C 的等温扩增替代方法吸引了人们的兴趣,以促进该检测方法转化为即时检测 (PoC) 分析平台。此外,目前在临床实验室中可用的最先进方法无法满足常规检测数十到数百个靶序列的可能性,具有单碱基特异性,这将是解决新兴病毒变体和抗生素耐药基因的重要手段。在这里,我们主张,锁式探针 (PLP) 由 Nilsson 等人于 1994 年首次报道,与滚环扩增 (RCA) 结合,称为 PLP-RCA,是当前等温核酸扩增检测 (NAAT) 领域中一种未充分利用的技术,提供了前所未有的多重检测、特异性、多功能性和易于集成到微型化 PoC 平台的特点。此外,PLP-RCA 的固有数字扩增保留了空间信息,并为通过感染细胞和组织的空间多组学分析探索发病机制开辟了新途径。本报告首先简要介绍 PLP-RCA,分别重点介绍三个主要的检测步骤,即 (1) PLP 设计和连接机制,(2) 探针连接后的 RCA,以及 (3) RCA 产物的检测。每个主题都简洁地介绍了,但提供了足够的细节,让读者了解一些检测的复杂性和灵活性程度,具体取决于手头的分析挑战。在使读者熟悉该方法后,我们讨论了我们小组和其他小组使用 PLP-RCA 进行病毒、细菌和真菌诊断的具体研究实例,包括抗生素耐药基因的基因分型和病毒亚型分析。然后,我们剖析了 PLP-RCA 微型化和集成方面的关键发展,以最大限度地减少用户输入,最大化分析通量,并加快结果时间,最终目标是实现即时检测应用。这些发展包括分子富集以实现最大灵敏度、空间阵列以最大化分析通量、自动化液体处理以简化微型设备中的分析工作流程,以及无缝集成信号转导以将 RCA 产物滴度(理想情况下还有空间信息)转化为可读输出。最后,我们将 PLP-RCA 置于当前的 NAAT 景观中,并进行系统的优势、劣势、机会和威胁分析,以揭示未打磨的边缘,发现具有普遍、精确和无偏的病原体诊断潜力的宝石。